Author Archive for: cclavel

You are here: / Caroline Clavel

Entries by Caroline Clavel

A new potent and stable DNA methyltransferase inhibitor developed by the Glycochemistry & Molecular Recognition team for cancer treatment

The researchers of the Glycochemistry & Molecular Recognition group of the IBMM have just published a paper on the Journal of Medicinal Chemistry, where they show the results of the rational optimisation of their flavanone derivatives as DNA methyltransferase (DNMT) inhibitors. Among the new synthesised compounds, they identified compound 34b, a novel dihalo-methoxyflavanone with high […]

Assistant Engineer or Research Engineer in Biomaterials Chemistry

Durée : 13 mois Début du contrat : 01/09/2025 Clôture des candidatures : 14/06/2025 Structure de rattachement : Institut des Biomolécules Max Mousseron (IBMM) Equipe : Peptides https://ibmm.umontpellier.fr/en/amino-acids-heterocycles-peptides-proteins/ Lieu : IBMM, Pole Chimie Balard, 1919 Route de Mende, Montpellier, France.   Intitulé du projet : Optimisation préclinique d’une thérapie par vésicules extracellulaires issues de cellules stromales mésenchymateuses dans la […]

Congratulations to Anna for winning the Best Oral Presentation Award at the 62nd SECO

A great piece of news to start the week: Anna Abramova (2nd-year PhD student at the SCB Doctoral School; IDIL-IBMM-SLB) received the Best Oral Presentation Award at the 62nd SECO (Study Week in Organic Chemistry), organized by our young colleagues in Fournols, located in the Livradois-Forez Regional Natural Park in the Puy-de-Dôme region. Her oral […]

Post-Doc Offer: MecAPeps, Mechanical growth of Analogues of Peptide macrocycleS

Who we are looking for: A highly motivated organic chemist, with an experience in biomolecules and 0-3 years post-PhD experience, willing to develop his/her research interests in a vibrant academic environment. Important criteria: his/her motivation should be reflected in a strong desire to apply to MSCA fellowship, ERC starting Grant, and/or University or CNRS permanent […]

PhD Offer: Chemical and Agronomic Valorization of Tanned Leather By-products with Silicon

OFFRE de THESE CIFRE (CTC/UM) A partir de janvier 2026     Contact : Ahmad Mehdi () ; Gilles Subra () ; Clara Desroches () ; Alfredo Napoli ()   Localisation : ICGM, Pôle Chimie Balard, Montpellier, équipe D3 www.icgm.fr/linstitut/les-departements/d3 IBMM, Pôle Chimie Balard, Montpellier, équipe Peptides www.ibmmpeptide.com CTC, Lyon, www.ctcgroupe.com CIRAD BiowooEB, Montpellier, ur-biowooeb.cirad.fr Les travaux se […]

The SLB team publishes recommendations on LC-MS/MS as part of an international collaboration.

Recently, experts in Mass Spectrometry, mainly Lipidomics specialists from around the world, have collaborated with the aim of providing the Oxylipin community with recommendations on LC-MS/MS for the analysis validating the biological interest of oxylipins, oxygenated metabolites of Polyunsaturated Fatty Acids (PUFAs). This collaborative work has just been published in the journal Sci Signaling. 96 […]

Tardigrades in “L’actualité chimique” this month!

Tardigrades are featured on the cover of the latest issue of Chemical News. Congratulations to Morgan PELLERANO, Myriam RICHAUD, and Simon GALAS! To see the cover: https://new.societechimiquedefrance.fr/numero/les-secrets-des-resistances-des-tardigrades-extremophiles-et-leurs-applications-p14-n503/ To read the article: https://new.societechimiquedefrance.fr/wp-content/uploads/2025/04/Galas-HD.pdf

Save the date : July 8th, 2025 – FICS is in Montpellier !

Students, post-docs… join us, present your work (poster) and take part in round-table discussions with industrialists at FICS 2025. The aim of the event, organized by the Industrial Chemistry Division of the Société Chimique de France and by the SCF Occitanie Méditerranée, is to bring together academia and industry, and in particular the new generation […]

PhD offer: Design and synthesis of multivalent epigenetic inhibitors

PhD offer in medicinal Chemistry and Chemical Biology Glycochemistry and Molecular Recognition Team Context and objective of the project – Epigenetic enzymes were identified as therapeutic targets in various diseases, including neurodegenerative diseases, schizophrenia, cancer and more recently in pulmonary and inflammation diseases. But selective targeting of epigenetic enzymes, e.g. HDACs, DNMT, and the understanding […]

 

Institut des Biomolécules Max Mousseron
UMR 5247
Pôle Chimie Balard Recherche
1919 route de Mende
34293 Montpellier